Gene · 6571
Papers3,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel human pluripotent stem cell-derived hypothalamus organoids demonstrate cellular diversity. | iScience | 2023 | 37646018 | PubTator, text mining | PubMed |
| Differentiating Between Lithium Tremors and Extrapyramidal Tremors in a Patient on Long-Term Antipsychotics and Lithium Medication. | Cureus | 2023 | 37637665 | PubTator, text mining | PubMed |
| Novel Pharmacological Targets of Post-Traumatic Stress Disorders. | Life (Basel) | 2023 | 37629588 | PubTator, text mining | PubMed |
| From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington's Disease Research. | Int J Mol Sci | 2023 | 37629202 | PubTator, text mining | PubMed |
| Beyond Motor Deficits: Environmental Enrichment Mitigates Huntington's Disease Effects in YAC128 Mice. | Int J Mol Sci | 2023 | 37628801 | PubTator, text mining | PubMed |
| Assessing and Modelling of Post-Traumatic Stress Disorder Using Molecular and Functional Biomarkers. | Biology (Basel) | 2023 | 37626936 | PubTator, text mining | PubMed |
| Brain-Derived Neurotrophic Factor Dysregulation as an Essential Pathological Feature in Huntington's Disease: Mechanisms and Potential Therapeutics. | Biomedicines | 2023 | 37626771 | PubTator, text mining | PubMed |
| Overview of Movement Disorders Secondary to Drugs. | Clin Pract | 2023 | 37623268 | PubTator, text mining | PubMed |
Efficacy and safety of Transcranial Direct Current Stimulation (tDCS) on cognitive function in chronic schizophrenia with Tardive Dyskinesia (TD): a randomized, double-blind, sham-controlled, clinical trial. | BMC Psychiatry | 2023 | 37620825 | PubTator, text mining | PubMed |
| Cross-species comparative analysis of single presynapses. | Sci Rep | 2023 | 37620363 | PubTator, text mining | PubMed |
| CRISPR/Cas9-based QF2 knock-in at the tyrosine hydroxylase (th) locus reveals novel th-expressing neuron populations in the zebrafish mid- and hindbrain. | Front Neuroanat | 2023 | 37603776 | PubTator, text mining | PubMed |
| Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. | Arch Toxicol | 2023 | 37597078 | PubTator, text mining | PubMed |
Dihydroxyphenylacetaldehyde Lowering Treatment Improves Locomotor and Neurochemical Abnormalities in the Rat Rotenone Model: Relevance to the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson's Disease. | Int J Mol Sci | 2023 | 37569897 | PubTator, text mining | PubMed |
| Harnessing the Power of Enteric Glial Cells' Plasticity and Multipotency for Advancing Regenerative Medicine. | Int J Mol Sci | 2023 | 37569849 | PubTator, text mining | PubMed |
| Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways. | J Biomed Sci | 2023 | 37568205 | PubTator, text mining | PubMed |
| Adipose tissue coregulates cognitive function. | Sci Adv | 2023 | 37566655 | PubTator, text mining | PubMed |
| Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy. | Sci Rep | 2023 | 37542143 | PubTator, text mining | PubMed |
| The Plasma Membrane Monoamine Transporter is Highly Expressed in Neuroblastoma and Functions as an mIBG Transporter. | J Pharmacol Exp Ther | 2023 | 37541765 | PubTator, text mining | PubMed |
| Molecular biology of serotonergic systems in avian brains. | Front Mol Neurosci | 2023 | 37538316 | PubTator, text mining | PubMed |
| How should we be using biomarkers in trials of disease modification in Parkinson's disease? | Brain | 2023 | 37536279 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6571/papers?page=14